Endocrine Disorders Induced by PD-1/PD-L1 Inhibitor and Related Treatment
Immune checkpoint therapy is a new mode of tumor therapy. At present, many kinds of PD-1/PD-L1 inhibitors have been approved for clinical application on various tumors, such as malignant melanoma, lung cancer, bladder cancer, lymphoma, etc. However, with the gradual promotion and application in clin...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | article |
| Language: | ZH |
| Published: |
Magazine House of Cancer Research on Prevention and Treatment
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/d8ae6841853849339273588500c2bc99 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|